SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 368 filers reported holding SAREPTA THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 1.02 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2019 | $1,216,000 | -50.2% | 8,000 | -61.0% | 0.08% | -65.3% |
Q1 2019 | $2,443,000 | +9.2% | 20,500 | 0.0% | 0.24% | -47.9% |
Q4 2018 | $2,237,000 | -32.4% | 20,500 | 0.0% | 0.45% | +105.9% |
Q3 2018 | $3,311,000 | -9.6% | 20,500 | -26.0% | 0.22% | -32.9% |
Q2 2018 | $3,664,000 | +59.4% | 27,720 | -10.6% | 0.33% | +47.7% |
Q1 2018 | $2,298,000 | -6.6% | 31,020 | -29.9% | 0.22% | -7.9% |
Q4 2017 | $2,460,000 | +16.6% | 44,220 | -4.9% | 0.24% | -45.7% |
Q3 2017 | $2,110,000 | -1.0% | 46,520 | -26.4% | 0.44% | -15.6% |
Q2 2017 | $2,131,000 | +207.9% | 63,220 | +170.5% | 0.53% | +154.1% |
Q1 2017 | $692,000 | -58.0% | 23,370 | -61.0% | 0.21% | -84.2% |
Q4 2016 | $1,646,000 | -83.2% | 60,000 | -62.5% | 1.31% | -65.8% |
Q3 2016 | $9,826,000 | +348.1% | 160,000 | +39.1% | 3.84% | +307.8% |
Q2 2016 | $2,193,000 | – | 115,000 | – | 0.94% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Avoro Capital Advisors LLC | 1,195,000 | $142,432,000 | 6.16% |
Casdin Capital, LLC | 305,000 | $36,353,000 | 3.99% |
Eventide Asset Management | 845,168 | $100,736,000 | 3.47% |
HIGHLINE CAPITAL MANAGEMENT, L.P. | 436,000 | $51,967,000 | 3.26% |
NEXTHERA CAPITAL LP | 21,270 | $2,535,000 | 3.08% |
Camber Capital Management LP | 500,000 | $59,595,000 | 2.97% |
Eversept Partners, LP | 83,574 | $9,961,185 | 2.91% |
CADIAN CAPITAL MANAGEMENT, LP | 610,546 | $72,771,000 | 2.84% |
RTW INVESTMENTS, LP | 338,199 | $40,310,000 | 2.75% |
Cormorant Asset Management, LP | 300,000 | $35,757,000 | 2.42% |